Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer

Journal of Clinical Oncology

Volumn 19, Issue 12, 2001, Pages 3025-3028

  Kantoff, P W ^a   Halabi, S ^a   Farmer, D A ^a   Hayes, D F ^a   Vogelzang, N A ^a   Small, E J ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SURAMIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION;

EID: 0035876118     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.12.3025     Document Type: Article

References (11)

1. Cancer of the prostate
2. Prognostic indicators in hormone refractory prostate cancer
3. Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage patients with prostate cancer
4. Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow-up confirms the potential utility of this assay in identifying patients more likely have biochemical recurrence (rising PSA) following radical prostatectomy
5. Detection of circulating prostate-derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence
6. Preoperative nested reverse transcription-polymerase chain reaction for prostate specific membrane antigen predicts biochemical recurrence after radical prostatectomy
7. Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma
8. Detection of circulating tumor cells in men with localized prostate cancer
9. Non-parametric estimation from incomplete observations
10. Non-parametric confidence limits for survival probabilities and median survival time
11. Regression models and life tables